blue-chip

Book Profit on this NYSE-Listed Consumer Staples Stock: Procter & Gamble Co.

Oct 31, 2022 | Team Kalkine

Read Time :5 min

Procter & Gamble Co.

Company Overview: The Procter & Gamble Company is committed to offering customers worldwide branded consumer packaged goods. The business is divided into five divisions: Baby, Feminine & Family Care; Beauty; Grooming; Health Care; Fabric & Home Care. The business primarily sells its goods through mass merchandisers, grocery stores, membership club stores, drugstores, department stores, distributors, wholesalers, baby stores, specialty beauty stores, e-commerce, high-frequency stores, pharmacies, electronics stores, and professional channels in about 180 countries and territories.

As per our previous US Dividend Income report published on PG on 12th October 2022, Kalkine provided a ‘Buy’ stance on the stock at USD 123.24 based on ‘Decent fundamentals, higher margin profile, lower balance sheet risk, positive outlook, associated risk, and valuation upside’ and the stock price has now moved by ~9.72% since then and the price has almost reached the Resistance 1 levels.

Noted below are the details of support and resistance levels provided in our previous report:

PG’s Daily Chart

Considering the resistance around the short-term 50-day SMA, close to target level attainment, and volatile market conditions on the back of rising interest rates, a ‘Sell’ rating is assigned to the “PG” at the closing market price of USD 135.22 (as of 28 October 2022).

Note: This report may be updated with details around fundamental and technical analysis, price/ chart in due course, as appropriate

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is 12^thOctober 2022. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the New York Stock Exchange (NYSE), NASDAQ Capital Markets (NASDAQ), and or REFINITIV. Typically, all sources (NYSE, NASDAQ, or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.’

Small-Cap

Watch Out for One NASDAQ- Listed Biotechnology Services Stock – Inotiv Inc